SCHEMBL29964396

SCHEMBL29964396

CC(=O)N1CC(Oc2ccc(-c3cc(-c4ccc5c(c4)CCNC5=O)c(N)nc3F)cc2)C1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.43
MAPKAPK2 P49137 8/20 0.41
PARP10 Q53GL7 5/20 0.41
PARP11 Q9NR21 5/20 0.41
PRKAB2 O43741 1/20 0.40
PRKAG1 P54619 1/20 0.40
PRKAA2 P54646 1/20 0.40
PRKAA1 Q13131 1/20 0.40
PRKAG3 Q9UGI9 1/20 0.40
PRKAG2 Q9UGJ0 1/20 0.40
PRKAB1 Q9Y478 1/20 0.40
MAPK9 P45984 1/20 0.39
GSK3B P49841 1/20 0.38
GABRG2 P18507 1/20 0.37
GABRB3 P28472 1/20 0.37
GABRA5 P31644 1/20 0.37
CHEK2 O96017 1/20 0.36
CDK4 P11802 1/20 0.35
CCND1 P24385 1/20 0.35
CCND3 P30281 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29964484 0.92 CHEK2 (0.44) MAPK1MAPKAPK2PARP10PARP11MAPK9
SCHEMBL29964469 0.90 PRKAB2 (0.39) MAPK1MAPKAPK2PARP10PARP11PRKAB2
SCHEMBL29965247 0.90 MAPK1 (0.40) MAPK1MAPKAPK2PARP10PARP11MAPK9
SCHEMBL29964473 0.88 MAPK1 (0.42) MAPK1MAPKAPK2PARP10PARP11MAPK9
SCHEMBL29965132 0.87 MAPK1 (0.43) MAPK1MAPKAPK2PARP10PARP11MAPK9
SCHEMBL29964708 0.85 MAPK1 (0.47) MAPK1MAPKAPK2PARP10PARP11MAPK9
SCHEMBL31079234 0.85 MAPK1 (0.45) MAPK1MAPKAPK2PARP10PARP11MAPK9
SCHEMBL29963910 0.85 MAPK1 (0.47) MAPK1MAPKAPK2PARP10PARP11MAPK9
SCHEMBL29964340 0.84 MAPK1 (0.48) MAPK1MAPKAPK2PARP10PARP11MAPK9
SCHEMBL31079323 0.84 MAPK1 (0.44) MAPK1MAPKAPK2PARP10PARP11MAPK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240343704-A1 HALO-SUBSTITUTED AMINO PYRIDINE COMPOUNDS AS INHIBITORS OF THE HAEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR) (CA) 2024-10-17 US disclosed
WO-2022226668-A1 HALO-SUBSTITUTED AMINO PYRIDINE COMPOUNDS AS INHIBITORS OF THE HAEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR) (CA) 2022-11-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240343704-A1 HALO-SUBSTITUTED AMINO PYRIDINE COMPOUNDS AS INHIBITORS OF THE HAEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) CMPK1, WNK1, AAK1 MAPK1 141/4885MAPKAPK2 79/4885PARP10 2072/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.